Previous Close | 12.15 |
Open | 12.06 |
Bid | 11.51 x 1000 |
Ask | 11.91 x 1800 |
Day's Range | 11.77 - 12.09 |
52 Week Range | 10.08 - 33.80 |
Volume | |
Avg. Volume | 1,177,150 |
Net Assets | 624.88M |
NAV | 11.78 |
PE Ratio (TTM) | N/A |
Yield | 0.60% |
YTD Daily Total Return | -53.85% |
Beta (5Y Monthly) | 0.00 |
Expense Ratio (net) | 0.73% |
Inception Date | 2020-09-01 |
Cresco Labs Inc. said Wednesday its second-quarter loss increased to $8.3 million from $2.65 million in the year-ago period. The company did not provide a loss per share figure. Second-quarter revenue increased by 4% to $218.2 million from $210 million. Wall Street analysts were expecting Cresco Labs to generate revenue of $218.3 million, according to a FactSet survey. Cresco Labs co-founder and CEO Charles Bachtell said the company reported "solid results in the face of an unprecedented macro e
Marijuana exchange-traded funds (ETFs) provide investors with exposure to equities of companies that engage in the cultivation, distribution, and sale of marijuana and related products. Products of marijuana companies include dried flowers, oils, seeds, edibles, and more.
While parts of Trulieve's business held steady, inflation and lower revenue in its wholesale unit weighed on results.